Article

Prenatal Vitamin D Supplementation and Child Respiratory Health: A Randomised Controlled Trial

Department of Paediatrics, Imperial College London, London, United Kingdom.
PLoS ONE (Impact Factor: 3.23). 06/2013; 8(6):e66627. DOI: 10.1371/journal.pone.0066627
Source: PubMed

ABSTRACT

Observational studies suggest high prenatal vitamin D intake may be associated with reduced childhood wheezing. We examined the effect of prenatal vitamin D on childhood wheezing in an interventional study.
We randomised 180 pregnant women at 27 weeks gestation to either no vitamin D, 800 IU ergocalciferol daily until delivery or single oral bolus of 200,000 IU cholecalciferol, in an ethnically stratified, randomised controlled trial. Supplementation improved but did not optimise vitamin D status. Researchers blind to allocation assessed offspring at 3 years. Primary outcome was any history of wheeze assessed by validated questionnaire. Secondary outcomes included atopy, respiratory infection, impulse oscillometry and exhaled nitric oxide. Primary analyses used logistic and linear regression.
We evaluated 158 of 180 (88%) offspring at age 3 years for the primary outcome. Atopy was assessed by skin test for 95 children (53%), serum IgE for 86 (48%), exhaled nitric oxide for 62 (34%) and impulse oscillometry of acceptable quality for 51 (28%). We found no difference between supplemented and control groups in risk of wheeze [no vitamin D: 14/50 (28%); any vitamin D: 26/108 (24%) (risk ratio 0.86; 95% confidence interval 0.49, 1.50; P = 0.69)]. There was no significant difference in atopy, eczema risk, lung function or exhaled nitric oxide between supplemented groups and controls.
Prenatal vitamin D supplementation in late pregnancy that had a modest effect on cord blood vitamin D level, was not associated with decreased wheezing in offspring at age three years.
Controlled-Trials.com ISRCTN68645785.

Download full-text

Full-text

Available from: John O Warner, Aug 20, 2014
  • Source
    • "However, this clinical trial has some limitations such as small size, initiation of vitamin D supplementation in late pregnancy, inadequate dose administration (800IU D2 daily or oral 200.000IU D3 bolus), while authors also acknowledged that it was not initially designed to assess the specific outcomes and was not double blind [154]. In order to overcome some of the limitations of the previous studies, two on-going randomized, controlled double blind trial are in progress, exploring earlier prenatal vitamin D supplementation in relation to its effects on childhood asthma and allergy at 3 years of age ([155] and ABCvitaminD NCT00856947). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Vitamin D has an indisputable immunodulatory role in both lung and immune system development, which is initiated during fetal life and is mainly accomplished in the first years of extrauterine life. Several published studies have shown that low levels of vitamin D may increase the risk of developing asthma and allergic diseases. Moreover, vitamin D deficiency epidemic reported over the last decades coincides with an increase in the prevalence of asthma and allergies in westernized societies. Since placental transfer of 25(OH)D is the major source of vitamin D in the developing fetus, important questions concerning the impact of maternal vitamin D status on the outcome of pregnancy have arisen. The aim of this review is to present the current evidence regarding the determinants of vitamin D status in pregnancy as well as its role in the development of asthma and allergies in early childhood.
    Full-text · Article · May 2015 · Mini Reviews in Medicinal Chemistry
  • Source
    • "However, a trial of supplementation with vitamin D in late pregnancy showed no effect on wheeze frequency or lung function in offspring by the age of 3 years.90 In this study, supplementation improved but did not optimize vitamin D status.90 "
    [Show abstract] [Hide abstract]
    ABSTRACT: In the last decade, many epidemiologic studies have investigated the link between vitamin D deficiency and asthma. Most studies have shown that vitamin D deficiency increases the risk of asthma and allergies. Low levels of vitamin D have been associated with asthma severity and loss of control, together with recurrent exacerbations. Remodeling is an early event in asthma described as a consequence of production of mediators and growth factors by inflammatory and resident bronchial cells. Consequently, lung function is altered, with a decrease in forced expiratory volume in one second and exacerbated airway hyperresponsiveness. Subepithelial fibrosis and airway smooth muscle cell hypertrophy are typical features of structural changes in the airways. In animal models, vitamin D deficiency enhances inflammation and bronchial anomalies. In severe asthma of childhood, major remodeling is observed in patients with low vitamin D levels. Conversely, the antifibrotic and antiproliferative effects of vitamin D in smooth muscle cells have been described in several experiments. In this review, we briefly summarize the current knowledge regarding the relationship between vitamin D and asthma, and focus on its effect on airway remodeling and its potential therapeutic impact for asthma.
    Full-text · Article · Apr 2014 · Journal of Asthma and Allergy
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There has been a steep rise in the burden of atopic dermatitis (AD), and up to 20% of children in developed countries now suffer of the disease. At present, treatment at best achieves symptom control rather than cure, and there is a strong need to identify new methods of disease prevention. While earlier approaches focused on allergen avoidance strategies, there has been a clear shift towards attempts to induce tolerance and enhancement of skin barrier function, as skin barrier breakdown plays an important role in AD development. This article reviews the latest developments in the prevention of AD.
    Preview · Article · Dec 2013 · Allergy
Show more